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Abstract Studies over the past 10 years have provided major
insights into the molecular mechanisms responsible for active
transport of macromolecules in and out of the nucleus.
Nucleocytoplasmic transport pathways correspond to active
and signal-mediated processes that involve substrates, adaptors
and receptors. Regulation of both nuclear import and nuclear
export is mainly exerted at the level of transport complex
formation and has emerged as one of the most efficient
mechanisms to adapt gene expression to the cell environment
by restricting the access of transcriptional regulators to their
target genes.
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1. Introduction
One of the de¢nitive features of eukaryotic cells is that
DNA is contained within a specialized compartment, the nu-
cleus, separated from the rest of the cell by a membranous
nuclear envelope. This compartmentalization results in the
physical separation of transcription and translation. In partic-
ular, proteins involved in the transcription and its regulation
in response to distinct physiological conditions have to be
expressed in the nucleus to ful¢ll their function. In this re-
spect, nuclear import and export represent important regula-
tory checkpoints in the control of gene expression.
2. Nuclear transport mechanisms
2.1. Import mechanisms
Molecular exchanges between the nucleus and the cyto-
plasm occur through a specialized structure of the nuclear
envelope, the nuclear pore complex (NPC). Polypeptides be-
low 40 kDa can in principle freely di¡use into the nucleus
through peripheral and central channels of the NPC although
very few proteins do so. Proteins above 40^60 kDa are im-
ported into the nucleus by a sequence-mediated process that
involves the binding of the protein to the NPC, its transloca-
tion through the central channel of the pore and its release in
the nucleoplasm [1].
Sequence-mediated nuclear import involves recognition of
speci¢c amino acid sequences called NLSs (for nuclear local-
ization sequences) within the karyophilic protein by speci¢c
receptors, called karyopherins (Kaps) or importins which be-
long to a wide family of proteins conserved throughout evo-
lution. Sequence similarity searches in yeast genome databases
identi¢ed 13 potential Kaps and six of them, termed KapL1/
Kap95p, KapL2/Kap104p, KapL3/Kap121p, KapL4/Kap124p,
Sxm1p/Kap108p and Nmd5p, have been actually implicated
in the nuclear import of various substrates. Some of their
homologues have been identi¢ed in higher eukaryotes but
there are still orphan Kaps and imported substrates in both
yeast and metazoans [2].
First identi¢ed in the SV40 large T antigen and in the Xe-
nopus nucleoplasmin, lysine-rich NLSs or basic NLSs are
present in a large number of proteins. The basic NLS receptor
is KapL1 (also called importin L or, in yeast, Kap95p), which
functions as a dimer with KapK (Kap60p or importin K), an
adaptor protein providing the basic NLS binding site. In met-
azoans, as many as ¢ve di¡erent KapK have been reported
and can be expressed in a tissue- and stimulus-dependent
manner. KapL1 also imports some proteins through direct
binding or acts as a heterodimer with an adaptor called snur-
portin to import snRNPs. Another well characterized NLS is
the M9 sequence in the vertebrate mRNA binding protein
hnRNPA1 that directly binds to KapL2/transportin. Similarly,
the yeast homologue of KapL2, Kap104p, is responsible for
the nuclear import of mRNA binding proteins [2].
Members of the KapL family share domains allowing inter-
action with some nucleoporins. The nuclear import substrate/
receptor complex ¢rst docks at cytoplasmic ¢brils extending
from the NPC prior to translocation through the NPC. This
poorly understood step involves two other proteins, p10 or
NTF2, whose role in the di¡erent translocation steps is not
clearly established, and a small GTPase of the Ras superfam-
ily, Ran. Ran is a very abundant protein (0.3^1% of total
proteins) that plays a key role in nucleocytoplasmic transport
(see also below for nuclear export). Like other GTPases, Ran
exists in GDP- and GTP-bound states. However, RCC1, the
Ran GDP exchange factor (RanGEF), is exclusively nuclear
whereas the Ran GTPase activating protein (RanGAP) as well
as the co-stimulatory factors RanBP1 and RanBP2 are cyto-
plasmic. This is thought to provide a gradient of Ran within
the cell with GTP-Ran in the nucleus and GDP-Ran in the
cytoplasm (Fig. 1A). Once the NPC is crossed, binding of
KapL to GTP-Ran on the nucleoplasmic side of the NPC
triggers dissociation of the import substrate/receptor interac-
tion and release of the import substrate into the nucleus (Fig.
1B). Ran therefore ensures directionality of the transport by
allowing dissociation of the nuclear import substrate/receptor
interaction in the nucleus. After nuclear import, Kaps (recep-
tors and eventual adaptors) are recycled back to the cyto-
plasm and are available for a new round of nuclear import
[3]. Translocation of cargoless KapL is a Ran-independent
process and some proteins, such as the viral protein Vpr,
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seem to be imported in a receptor- and Ran-independent man-
ner possibly due to similarities to KapL and binding to the
same nucleoporins [4].
2.2. Export mechanisms
More than 40 years ago, nuclear transplantation experi-
ments demonstrated that some proteins migrate (shuttle) be-
tween the nucleus and the cytoplasm of amebas. Shuttling
proteins in others organisms have more recently been identi-
¢ed by antibody microinjection and interspecies heterokaryon
formation assays [1]. Export of a nuclear protein is primarily
limited by the extent of its interaction with other nuclear
components. For example, a non-shuttling protein such as
lamin B2 can be converted into a shuttling protein by intro-
ducing mutations that impair its ability to polymerize at the
nuclear membrane [5].
Three major groups of proteins can be distinguished from
their export kinetics in interspecies heterokaryons or nuclear
microinjection assays. The ¢rst group, represented by some
major nucleolar proteins, nucleolin and B23/No38, is trans-
ported slowly from the nucleus to the cytoplasm (12^24 h) [5],
but the role and mechanism of this pathway are still un-
known. The second group of proteins displays faster nuclear
export kinetic (4 h in the heterokaryon assay) and is illus-
trated by the glucocorticoid receptor (GR) [6]. This transport
pathway is an ATP-dependent and cytosol-independent proc-
ess that involves tyrosine phosphorylation [7]. Proteins from
the third group are exported very e⁄ciently out of the nucleus
(45 min for the HIV-1 Rev protein [8]) and this pathway
involves speci¢c nuclear export signals (NES) present in the
export substrate. The M9 sequence of hnRNP A1 confers
ability of both nuclear import and export to this protein sug-
gesting that kapL2/transportin could also be involved in nu-
clear export of hnRNP A1 [9]. Another NES identi¢ed in an
increasing number of cellular or viral proteins is a leucine-rich
sequence in which leucine residues are critical for targeting
proteins out of the nucleus. Two receptors responsible for
nuclear protein export or exportins have been identi¢ed so
far. CRM1 speci¢cally interacts with leucine-rich NES [10^
13] whereas CAS 1 mediates nuclear export of importin K
whose NES is unknown [14]. Both exportins are related to
the KapL family and are able to interact with NPCs and
Ran-GTP. Exportins bind their substrates in a RanGTP-de-
pendent way [11,14] but GTP hydrolysis is not required for
translocation [15] (Fig. 1B). However, in the cytoplasm, stim-
ulation of GTP hydrolysis on Ran by concerted action of
RanGAP, RanBP1 and RanBP2 is thought to trigger dissoci-
ation of the exported protein from its receptor that is subse-
quently recycled back to the nucleus.
3. Nuclear transport and transcriptional regulation
Regulating the access of a transcriptional regulator to the
nuclear compartment has been proved over the past years to
represent a common way to switch transcription on or o¡.
Considering the receptor-mediated nuclear transport mecha-
nism, regulation could occur at various steps. However, a
number of studies point out that regulation of nuclear trans-
port is mainly exerted at the level of the transport substrate
rather than at the level of the transport machinery. The di¡er-
ent ways reported so far to regulate nuclear import and export
of transcriptional regulators are summarized in Fig. 2.
3.1. Cytoplasmic or nuclear anchoring
In the ¢rst situation, the transport sequence of the tran-
scriptional regulator is accessible to the nuclear transport re-
ceptor but the substrate is anchored in the cytoplasm or in the
nucleus by a mechanism that overrides the presence of any
NLS or NES. In particular, nuclear import of transmembrane
proteins depends on cleavage of the cytosolic tail that can be
subsequently transported into the nucleus. Under normal con-
ditions, the entire sterol regulatory element binding protein
(SREBP) is inserted in the endoplasmic reticulum membrane.
Sterol depletion triggers a SREBP cleavage activating protein
(SCAP)-dependent proteolytic cleavage of the NH2-terminal
domain of SREBPs that contains a basic NLS and a tran-
scriptional activator region (Fig. 2a). In the nucleus, this do-
main promotes expression of genes encoding enzymes in-
volved in the cholesterol biosynthetic pathway [16].
Cytoplasmic anchoring has also been observed for non-mem-
branous proteins such as the thermosensitive p53Val135 that
interacts with the vimentin cytoskeleton at the restrictive tem-
Fig. 1. A: The Ran GTPase cycle. The Ran GDP exchange factor RCC1 (Regulator of Chromosome Condensation 1) is exclusively expressed
in the nucleus whereas the Ran GTPase activating protein RanGAP and the costimulatory Ran binding proteins RanBP1 and 2 are cytoplas-
mic. B: General model of nucleocytoplasmic transport. Nuclear import receptors (Ri) bind import substrates in the absence of RanGTP (in the
cytoplasm) and dissociate from them in the presence of RanGTP (in the nucleus) whereas nuclear export receptors (Re) bind export substrates
in the presence of RanGTP (in the nucleus) and release them after GTP hydrolysis (in the cytoplasm).
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perature and accumulates in the nucleus at the permissive
temperature [17] or the Xenopus factors xnf7 and XMyoD,
which are retained in the cytoplasm by an unknown mecha-
nism [18,19] (Fig. 2b).
Nuclear export of transcription regulators can also be pre-
vented by their anchorage on nuclear components, particu-
larly on chromatin. In the presence of hormone, glucocorti-
coid receptor (GR)associates with its speci¢c promoter
targets. Upon hormone withdrawal, a rapid release of gluco-
corticoid receptor from chromatin is observed that is followed
by the nuclear export of GR back to the cytoplasm, where it
can respond to a secondary hormone challenge [7] (Fig. 2b).
3.2. Masking/unmasking of the transport sequence
In other cases, the nuclear transport sequence is masked
either as a consequence of a conformational change or by
an interacting partner until a modi¢cation unmasks it. Se-
quence masking/unmasking can be achieved by post-transla-
tional modi¢cation of the transport substrate itself, can in-
volve the degradation or dissociation of an inhibitory
protein or, in contrast, can be due to association with another
protein.
The most frequent post-translational modi¢cations reported
so far to regulate nuclear transport sequence/receptor interac-
tion are dephosphorylation and phosphorylation and a large
number of examples illustrates this major regulation route
(Fig. 2c,cP). A well characterized dephosphorylation-depend-
ent NLS unmasking coupled to phosphorylation-dependent
NES unmasking is illustrated by the regulation of the yeast
transcription factor Pho4. In the absence of phosphate in the
growth medium, Pho4 is underphosphorylated and directly
interacts with its nuclear import receptor, Kap121p/KapL3
[20]. When expressed in the nucleus, Pho4 activates transcrip-
tion of phosphate-responsive genes. In the presence of phos-
phate in the growth medium, nuclear Pho4 becomes phos-
phorylated by the cyclin/cyclin-dependent kinase pair Pho80-
Pho85. This modi¢ed form of Pho4 is then able to interact
with nuclear export receptor Msn5 and is e⁄ciently exported
back to the cytoplasm where its phosphorylation inhibits the
interaction with the import receptor [21]. Dephosphorylation/
phosphorylation thus provides a nuclear import and export
switch that tightly regulates the subcellular localization and
consequently the transcriptional activity of Pho4 as a function
of extracellular phosphate concentration. The nucleocytoplas-
mic distribution of the transcription factor NF-AT is regu-
lated following a similar scheme. In resting T cells, NF-AT
resides in the cytoplasm but upon TCR and CD28 coreceptor
engagement, elevation of intracellular calcium triggers activa-
tion of the phosphatase calcineurin that dephosphorylates
NF-AT resulting in its NLS unmasking and subsequent nu-
clear import. Upon return of calcium to resting levels, nuclear
NF-AT is phosphorylated by glycogen synthase kinase-3 al-
lowing the NES to be exposed and NF-AT is thus exported
out of the nucleus through its interaction with CRM1 [22]. In
contrast, oxidation of the yeast AP-1-like transcription factor
Yap1p prevents its nuclear export by masking the NES [23].
Yap1p is therefore maintained in the nucleus where it acti-
vates genes involved in the stress response.
When a nuclear transport sequence is masked through an
interaction with an inhibitory factor, its exposure can be en-
Fig. 2. Di¡erent ways to regulate the accessibility of a transport substrate (S) to the transport machinery. Access can be regulated by the cyto-
plasmic or nuclear anchoring of S to a membrane (a) or to another structure (b). Alternatively, availability of the nuclear transport sequence
of S can be regulated by post-translational modi¢cation (c and cP), association with an inhibitor (d or dP) or an activator (e) protein or interac-
tion with a protein that carries the transport sequence (f). Numbers in square brackets refer to references; refs. [36^41] only described here.
FEBS 21994 2-6-99 Cyaan Magenta Geel Zwart
P. Turpin et al./FEBS Letters 452 (1999) 82^8684
sured by proteolysis of the inhibitor (Fig. 2d). The best char-
acterized example of such a regulation concerns the NF-UB
transcription factor. In most unstimulated cells, NF-UB inter-
act with inhibitory molecules called IUBs that directly mask
NF-UB NLSs [24]. The stimulation of cells with cytokines or
various environmental stresses leads to the phosphorylation of
IUBs. For most inducers, phosphorylation occurs on con-
served serines and targets IUBs for ubiquitination and degra-
dation by the proteasome. IUB-free NF-UB then interacts with
the basic NLS receptor and is imported into the nucleus where
it activates responsive genes [25].
Dissociation of the transport substrate/inhibitor complex
can also lead to NLS or NES unmasking. The conformational
change that triggers dissociation from the inhibitory molecule
can be due either to post-translational modi¢cations or to the
binding of a di¡erent transport substrate partner. In the case
of the glucocorticoid receptor, hormone binding to its recep-
tor triggers dissociation of the inhibitory hsp90 and NLS un-
masking [26] (Fig. 2dP). The nuclear transport substrate can
also interact with an activator protein that unmasks the NLS
or the NES (Fig. 2e). This is illustrated by the mammalian
ERK2 MAP kinase that translocates into the nucleus upon
phosphorylation and homodimerization [27]. PKI, a speci¢c
inhibitor of the catalytic subunit (C) of the cAMP-dependent
protein kinase, contains an NES only exposed when PKI
binds to C thus limiting the kinase activity of C in the nuclear
compartment [28].
3.3. Piggy-back
Finally, some transcriptional regulators do not contain any
NLS or NES but their interaction with speci¢c partners bear-
ing nuclear transport sequences results in their nuclear import
or export by a mechanism called piggy-back (Fig. 3f). This is
illustrated by the nuclear import of the pancreatic transcrip-
tion factor-1 (PTF-1) whereby the p75 subunit directs the
cytoplasmic form of PTF-1 (p48/p64 heterodimer) to the nu-
cleus [29]. Similarly, p53 is exported from the nucleus to the
cytoplasm through its interaction with hdm2 which contains
an NES. This nuclear transport is required for the protea-
some-dependent degradation of p53 which occurs in the cyto-
plasm [30]. The piggy-back mechanism provides the cell with a
supplementary regulation level since modulation of both the
transport sequence and the interaction between the transport
substrate and the NLS- or NES-bearing protein can be
achieved.
4. Regulation of NF-UB-dependent transcription
Over the past few years, transcriptional activity of NF-UB
has been shown to be tightly regulated by nucleocytoplasmic
Fig. 3. Regulation of NF-UB-dependent transcription. In unstimulated cells, interaction with IUB masks NF-UB NLS. Stimulation of cells leads
to the degradation of IUBs (1) and nuclear translocation of NF-UB (2). In the nucleus, NF-UB activates the transcription of responsive genes
(3) and in particular the gene encoding IUBK (4). Neosynthesized IUBK is transported to the nucleus by a piggy-back mechanism involving an
unknown protein (X) that carries a lysine-rich NLS (5). In the nucleus, IUBK interacts with NF-UB (6) and terminates NF-UB-dependent tran-
scription by inhibiting NF-UB/DNA interaction (7) and by exporting NF-UB out of the nucleus,through a leucine-rich NES within IUBK (8).
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tra⁄cking. NF-UB transcription factors are involved in the
control of apoptotic, in£ammatory, immune as well as viral
responses and share a Rel homology domain that contains a
lysine-rich NLS and a DNA binding domain. In most un-
stimulated cells, interaction with inhibitory proteins, IUBs,
masks NF-UB NLS and inhibits DNA binding in vitro. Stim-
ulation of cells with pathogens, cytokines or environmental
stresses activates a cascade of kinases leading to the phos-
phorylation of IUB and its subsequent ubiquitination and deg-
radation by the proteasome (Fig. 3, step 1). Once IUB de-
graded, the NLS of NF-UB is unmasked and NF-UB
proteins are transported in the nucleus (step 2) where they
activate the transcription of responsive genes (step 3). In par-
ticular, NF-UB promotes the transcription of the gene encod-
ing IUBK thus inducing a massive neosynthesis of IUBK [25]
(step 4). Neosynthesized IUBK is transported into the nucleus
by a piggy-back mechanism through interaction with an un-
known protein (X) that carries a lysine-rich NLS [31,32] (step
5). In the nucleus, IUBK interacts with NF-UB (step 6) and
terminates NF-UB-dependent transcription by inhibiting NF-
UB/DNA interaction (step 7) and exporting NF-UB out of the
nucleus. This latter function is ensured by a leucine-rich NES
within IUBK [12,33] (step 8). In addition to its role in the post-
inductional repression of transcription, e⁄cient export is also
essential for maintaining a low level of IUBK in the nucleus
and allowing NF-UB to be transcriptionally active upon cell
stimulation [34]. Finally, another member of the IUB family,
IUBL, can also in some cases be imported into the nucleus
where it interacts with NF-UB but without dissociating NF-
UB from DNA and thus protects NF-UB from IUBK [35].
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